Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents
Roden, D.M.
Postgraduate Medicine 78(4): 28-37
1985
ISSN/ISBN: 0032-5481 PMID: 2412217 Document Number: 243230
Document emailed within 1 workday
Related Documents
Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199Follath, F. 1991: Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements Journal of Cardiovascular Pharmacology 17(Suppl 6): S74-S76
Caillard, C.G.; Louis, J.C. 1980: Assessment of antiarrhythmic drugs in experimental pharmacology Methods and Findings in Experimental and Clinical Pharmacology 2(5): 223-252
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Danahy, D.T.; Aronow, W.S. 1977: Propranolol and lidocaine. Clinical use as antiarrhythmic agents Postgraduate Medicine 61(1): 113-117
Yanaginuma, T. 1984: Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits Josanpu Zasshi 38(6): 526-530
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355
Rosenbaum, A.H.; Maruta, T.; Richelson, E. 1979: Series on pharmacology in practice: 1. Drugs that alter mood. I. Tricyclic agents and monoamine oxidase inhibitors Mayo Clinic Proceedings 54(5): 335-344
Pfisterer, M. 1991: Negative inotropic effects of antiarrhythmic drugs: a clinical point of view Journal of Cardiovascular Pharmacology 17(Suppl 6): S44-S47
Cuena Boy, R.; Azanza Perea, J.R.; Honorato Pérez, J. 1983: Clinical pharmacology of antilipemic agents Revista de Medicina de la Universidad de Navarra 27(1): 25-28
Rahn, K.H. 1975: Clinical pharmacology of anti-arrhythmia agents Medizinische Klinik 70(23): 994
Rahn, K.H. 1983: Clinical pharmacology of the newer antihypertensive agents Der Internist 24(3): 128-134
Zeng, G.Y. 1983: Clinical pharmacology of anti-arrhythmia agents Zhonghua Xin Xue Guan Bing Za Zhi 11(1): 15-19
Azanza Perea, J.R.; Honorato Pérez, J.M.; Cuena Boy, R. 1984: Clinical pharmacology of anti-arrhythmia agents Revista de Medicina de la Universidad de Navarra 28(1): 37-43
Louis, R.; Radermecker, M. 1991: Anti-asthmatic agents. from pharmacology to clinical aspects Revue Medicale de Liege 46(2): 58-81
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Votchal, B.E.; Zamotaev, I.P.; Maksimova, L.N. 1975: Clinical pharmacology of bronchodilator agents of the sympathomimetic series Klinicheskaia Meditsina 52(5): 43-46
Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33
Cepeláková, H.; Petrlík, M.; Cepelák, V.; Roubal, Z. 1979: Clinical pharmacology of phlebotropic drugs Folia Haematologica 106(5-6): 714-723